Current Progress and Development of Cancer Vaccines

mwymwAbstract:Due to the accumulation of DNA damage over time, an increased human lifespan leads to higher cancer incidence and mortality rates, leading to the need for more effective prevention and treatment strategies. Cancer vaccines are emerging as an innovative and promising type of immunotherapy, offering the potential for personalized, less toxic treatments that enhance long-term immune surveillance and response. This review delves into the cutting-edge progress of cancer vaccine development, emphasizing their unique ability to empower the immune system to detect and destroy cancer. Despite significant progress, the development of these vaccines faces daunting challenges related to tumor diversity, immune suppression and evasion, and the complexity of vaccine production. The use of new technologies, including artificial intelligence and genomics, may be the key to overcoming these barriers. This paper explores how innovation is pushing the boundaries of what’s possible in the fight against this unforgiving disease. The future of cancer therapy may just lie in a shot of hope.

Authors

Institutions

Publication Details

Journal
MedScien
Published
2024-12-31
DOI
https://doi.org/10.61173/29kj9d65
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current Progress and Development of Cancer Vaccines

Jiaxin Zhou
MedScien
Immunotherapy and Immune Responses
article

Current Progress and Development of Cancer Vaccines

Jiaxin Zhou
article en

Abstract

mwymwAbstract:Due to the accumulation of DNA damage over time, an increased human lifespan leads to higher cancer incidence and mortality rates, leading to the need for more effective prevention and treatment strategies. Cancer vaccines are emerging as an innovative and promising type of immunotherapy, offering the potential for personalized, less toxic treatments that enhance long-term immune surveillance and response. This review delves into the cutting-edge progress of cancer vaccine development, emphasizing their unique ability to empower the immune system to detect and destroy cancer. Despite significant progress, the development of these vaccines faces daunting challenges related to tumor diversity, immune suppression and evasion, and the complexity of vaccine production. The use of new technologies, including artificial intelligence and genomics, may be the key to overcoming these barriers. This paper explores how innovation is pushing the boundaries of what’s possible in the fight against this unforgiving disease. The future of cancer therapy may just lie in a shot of hope.

MedScienVol. 1(10)
University of San Diego (US), University of California San Diego (US)
Good health and well-being
Openalex Percentile: Top 69%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.